Prestige Consumer Healthcare Inc
NYSE:PBH
Balance Sheet
Balance Sheet Decomposition
Prestige Consumer Healthcare Inc
Current Assets | 393.8m |
Cash & Short-Term Investments | 63.6m |
Receivables | 174.3m |
Other Current Assets | 155.9m |
Non-Current Assets | 2.9B |
PP&E | 83.3m |
Intangibles | 2.9B |
Other Non-Current Assets | 6.3m |
Current Liabilities | 127.4m |
Accounts Payable | 39.3m |
Accrued Liabilities | 80m |
Other Current Liabilities | 8.1m |
Non-Current Liabilities | 1.6B |
Long-Term Debt | 1.2B |
Other Non-Current Liabilities | 412.2m |
Balance Sheet
Prestige Consumer Healthcare Inc
Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
28
|
21
|
27
|
42
|
33
|
28
|
95
|
32
|
27
|
58
|
|
Cash Equivalents |
28
|
21
|
27
|
42
|
33
|
28
|
95
|
32
|
27
|
58
|
|
Total Receivables |
65
|
88
|
95
|
137
|
141
|
149
|
151
|
115
|
139
|
167
|
|
Accounts Receivables |
65
|
86
|
94
|
135
|
140
|
148
|
150
|
115
|
139
|
167
|
|
Other Receivables |
0
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
Inventory |
66
|
74
|
91
|
116
|
119
|
120
|
116
|
115
|
120
|
162
|
|
Other Current Assets |
18
|
19
|
35
|
40
|
12
|
5
|
4
|
8
|
6
|
4
|
|
Total Current Assets |
177
|
202
|
249
|
334
|
304
|
301
|
366
|
270
|
293
|
392
|
|
PP&E Net |
10
|
14
|
16
|
51
|
53
|
51
|
91
|
103
|
99
|
90
|
|
PP&E Gross |
10
|
14
|
16
|
51
|
53
|
51
|
91
|
103
|
99
|
90
|
|
Accumulated Depreciation |
8
|
12
|
15
|
20
|
30
|
39
|
46
|
54
|
61
|
67
|
|
Intangible Assets |
1 395
|
2 135
|
2 323
|
2 904
|
2 781
|
2 507
|
2 479
|
2 476
|
2 697
|
2 342
|
|
Goodwill |
191
|
291
|
360
|
615
|
620
|
579
|
575
|
578
|
579
|
528
|
|
Other Long-Term Assets |
23
|
1
|
1
|
8
|
4
|
3
|
3
|
3
|
3
|
3
|
|
Other Assets |
191
|
291
|
360
|
615
|
620
|
579
|
575
|
578
|
579
|
528
|
|
Total Assets |
1 796
N/A
|
2 642
+47%
|
2 949
+12%
|
3 911
+33%
|
3 761
-4%
|
3 441
-8%
|
3 514
+2%
|
3 429
-2%
|
3 671
+7%
|
3 354
-9%
|
|
Liabilities | |||||||||||
Accounts Payable |
48
|
46
|
38
|
70
|
61
|
57
|
62
|
46
|
56
|
63
|
|
Accrued Liabilities |
34
|
50
|
58
|
69
|
60
|
70
|
81
|
72
|
82
|
84
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
3
|
|
Other Current Liabilities |
2
|
3
|
10
|
23
|
2
|
0
|
5
|
2
|
3
|
11
|
|
Total Current Liabilities |
84
|
99
|
107
|
162
|
123
|
127
|
150
|
122
|
143
|
161
|
|
Long-Term Debt |
934
|
1 561
|
1 625
|
2 194
|
1 993
|
1 799
|
1 735
|
1 487
|
1 481
|
1 347
|
|
Deferred Income Tax |
213
|
352
|
470
|
715
|
443
|
400
|
408
|
434
|
445
|
380
|
|
Other Liabilities |
0
|
3
|
3
|
18
|
23
|
20
|
50
|
28
|
24
|
18
|
|
Total Liabilities |
1 232
N/A
|
2 014
+63%
|
2 205
+9%
|
3 089
+40%
|
2 582
-16%
|
2 345
-9%
|
2 343
0%
|
2 071
-12%
|
2 093
+1%
|
1 907
-9%
|
|
Equity | |||||||||||
Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Retained Earnings |
149
|
227
|
327
|
397
|
736
|
702
|
844
|
1 009
|
1 214
|
1 132
|
|
Additional Paid In Capital |
414
|
427
|
445
|
458
|
469
|
479
|
488
|
500
|
516
|
535
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
2
|
0
|
0
|
|
Treasury Stock |
1
|
4
|
5
|
7
|
8
|
60
|
118
|
131
|
134
|
189
|
|
Other Equity |
1
|
23
|
24
|
26
|
19
|
26
|
39
|
18
|
19
|
32
|
|
Total Equity |
563
N/A
|
628
+11%
|
744
+19%
|
823
+11%
|
1 179
+43%
|
1 096
-7%
|
1 171
+7%
|
1 358
+16%
|
1 578
+16%
|
1 447
-8%
|
|
Total Liabilities & Equity |
1 796
N/A
|
2 642
+47%
|
2 949
+12%
|
3 911
+33%
|
3 761
-4%
|
3 441
-8%
|
3 514
+2%
|
3 429
-2%
|
3 671
+7%
|
3 354
-9%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
52
|
52
|
53
|
53
|
53
|
52
|
50
|
50
|
50
|
50
|